Register Login

TSCAN THERAPEUTICS, INC. (TCRX)

(10% Negative) TSCAN THERAPEUTICS, INC. (TCRX) Announces Delay in enrollment Trials for vivo solid tumor program Due to Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

Full text
Register to leave comments
  • News bot Sept. 2, 2026, 11:23 a.m.

    📋 TSCAN THERAPEUTICS, INC. (TCRX) - Clinical Trial Update

    Filing Date: 2026-09-02

    Accepted: 2026-09-02 07:22:04

    Event Type: Clinical Trial Update

    Event Details:

    TSCAN THERAPEUTICS, INC. (TCRX) Announces Clinical Trial Update TSCAN THERAPEUTICS, INC. (TCRX) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: enrollment, patients
    • Diseases/Conditions: vivo solid tumor program, cancer
    • Clinical Stage: Phase 3, Phase 1
    • Update Type: Trial Timeline Adjustment
    • Primary Factors: Patient Enrollment, Regulatory Process
    • Collaboration: Cohort C
    • Updated Timeline: Q4 2027
      • targeting PRAME and the other targeting MAGE-A4, into IND-enabling studies. The Company believes its in vivo engineering approach will overcome the key limitations of ex vivo-engineered autologous TCR-T, including the cost and difficulty of patient-specific manufacturing, the delay in getting product to patients, and the need for lymphodepletion. The Company expects to share preclinical data in Q1 2027

    🔬 Clinical Development Pipeline (TSCAN THERAPEUTICS, INC.):

    Product Type Development Stage Therapeutic Area Source
    Control Other Phase PHASE3 AML ClinicalTrials.gov
    TSC-101 Other Phase PHASE3 AML ClinicalTrials.gov
    SOC + TSC-100 Other Phase PHASE1 AML ClinicalTrials.gov
    SOC + TSC-101 Other Phase PHASE1 AML ClinicalTrials.gov
    Observational Other Preclinical AML ClinicalTrials.gov
    Tumor Biopsy Other Preclinical Solid Tumor, Adult ClinicalTrials.gov
    TSC-201-B0702 + TSC-202-A0201 Other Phase PHASE1 Head and Neck Cancer ClinicalTrials.gov
    TSC-204-A0101 + TSC-202-A0201 Other Phase PHASE1 Head and Neck Cancer ClinicalTrials.gov
    TSC-203-A0201 + TSC-202-A0201 Other Phase PHASE1 Head and Neck Cancer ClinicalTrials.gov
    TSC-200-A0201 + TSC-202-A0201 Other Phase PHASE1 Head and Neck Cancer ClinicalTrials.gov
    TSC-204-C0702 + TSC-202-A0201 Other Phase PHASE1 Head and Neck Cancer ClinicalTrials.gov
    TSC-204-A0201 + TSC-202-A0201 Other Phase PHASE1 Head and Neck Cancer ClinicalTrials.gov
    TSC-202-A0201 Other Phase PHASE1 Head and Neck Cancer ClinicalTrials.gov
    TSC-203-A0201 + TSC-201-B0702 Other Phase PHASE1 Head and Neck Cancer ClinicalTrials.gov
    TSC-203-A0201 + TSC-204-A0101 Other Phase PHASE1 Head and Neck Cancer ClinicalTrials.gov
    TSC-200-A0201 + TSC-201-B0702 Other Phase PHASE1 Head and Neck Cancer ClinicalTrials.gov
    TSC-200-A0201 + TSC-204-A0101 Other Phase PHASE1 Head and Neck Cancer ClinicalTrials.gov
    TSC-204-C0702 + TSC-201-B0702 Other Phase PHASE1 Head and Neck Cancer ClinicalTrials.gov
    TSC-204-C0702 + TSC-204-A0101 Other Phase PHASE1 Head and Neck Cancer ClinicalTrials.gov
    TSC-204-A0201 + TSC-201-B0702 Other Phase PHASE1 Head and Neck Cancer ClinicalTrials.gov
    TSC-204-A0201 + TSC-204-A0101 Other Phase PHASE1 Head and Neck Cancer ClinicalTrials.gov
    TSC-201-B0702 Other Phase PHASE1 Head and Neck Cancer ClinicalTrials.gov
    TSC-204-A0101 Other Phase PHASE1 Head and Neck Cancer ClinicalTrials.gov
    TSC-203-A0201 Other Phase PHASE1 Head and Neck Cancer ClinicalTrials.gov
    TSC-200-A0201 + TSC-203-A0201 Other Phase PHASE1 Head and Neck Cancer ClinicalTrials.gov
    TSC-204-C0702 + TSC-203-A0201 Other Phase PHASE1 Head and Neck Cancer ClinicalTrials.gov
    TSC-204-A0201 + TSC-203-A0201 Other Phase PHASE1 Head and Neck Cancer ClinicalTrials.gov
    TSC-204-C0702 + TSC-200-A0201 Other Phase PHASE1 Head and Neck Cancer ClinicalTrials.gov
    TSC-204-A0201 + TSC-200-A0201 Other Phase PHASE1 Head and Neck Cancer ClinicalTrials.gov
    TSC-204-A0201 + TSC-204-C0702 Other Phase PHASE1 Head and Neck Cancer ClinicalTrials.gov
    TSC-200-A0201 Other Phase PHASE1 Head and Neck Cancer ClinicalTrials.gov
    TSC-204-C0702 Other Phase PHASE1 Head and Neck Cancer ClinicalTrials.gov
    TSC-204-A0201 Other Phase PHASE1 Head and Neck Cancer ClinicalTrials.gov
    Tumor and HLA Profiling Other Preclinical Head and Neck Cancer ClinicalTrials.gov
    Companion blood samples with procedure Procedure Preclinical Autoimmune Diseases ClinicalTrials.gov

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: TSCAN THERAPEUTICS, INC.
    • Ticker Symbol: TCRX

Search

News categories